HRP940270A2 - Systems for controlled release of pilocarpine - Google Patents

Systems for controlled release of pilocarpine

Info

Publication number
HRP940270A2
HRP940270A2 HRP4313928.0A HRP940270A HRP940270A2 HR P940270 A2 HRP940270 A2 HR P940270A2 HR P940270 A HRP940270 A HR P940270A HR P940270 A2 HRP940270 A2 HR P940270A2
Authority
HR
Croatia
Prior art keywords
pilocarpine
systems
controlled release
release
controlled
Prior art date
Application number
HRP4313928.0A
Other languages
English (en)
Inventor
Lothar Deurer
Otto Karlheinz
Thomas Hille
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HRP940270A2 publication Critical patent/HRP940270A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP4313928.0A 1993-04-28 1994-04-27 Systems for controlled release of pilocarpine HRP940270A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4313928A DE4313928C2 (de) 1993-04-28 1993-04-28 Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
HRP940270A2 true HRP940270A2 (en) 1996-08-31

Family

ID=6486612

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP4313928.0A HRP940270A2 (en) 1993-04-28 1994-04-27 Systems for controlled release of pilocarpine

Country Status (19)

Country Link
US (1) US5869086A (de)
EP (1) EP0695182A1 (de)
JP (1) JPH08509716A (de)
KR (1) KR960702308A (de)
AU (1) AU694115B2 (de)
CA (1) CA2161520A1 (de)
CZ (1) CZ277995A3 (de)
DE (1) DE4313928C2 (de)
FI (1) FI955161A (de)
HR (1) HRP940270A2 (de)
HU (1) HU220045B (de)
IL (1) IL109340A (de)
NO (1) NO309174B1 (de)
NZ (1) NZ265950A (de)
PL (1) PL175077B1 (de)
SK (1) SK134395A3 (de)
WO (1) WO1994025025A2 (de)
YU (1) YU22894A (de)
ZA (1) ZA942874B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
AU719171B2 (en) * 1995-01-14 2000-05-04 Abbott Laboratories A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
WO2001026648A1 (fr) 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee
DE10246503A1 (de) * 2002-03-26 2003-10-16 Tesa Ag Verwendung von Haftklebemassen für medizinische Verklebungen
KR20120035220A (ko) * 2003-01-22 2012-04-13 센주 세이야꾸 가부시키가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환 치료약의 눈의 국소 조직으로의 이행 방법
DE602005019724D1 (de) * 2004-05-21 2010-04-15 Senju Pharma Co Ophthalmologische perkutan absorbierbare zubereitung enthaltend einen muscarin-rezeptor-agonist
CN101123948A (zh) * 2005-02-17 2008-02-13 千寿制药株式会社 眼科用固体外用药剂
JPWO2007013661A1 (ja) * 2005-07-26 2009-02-12 千寿製薬株式会社 眼科用経皮吸収型製剤
US20100323978A1 (en) * 2009-06-22 2010-12-23 Calvin Hanna Non-aqueous oil delivery system for ophthalmic drugs
EP2606895A4 (de) * 2010-10-12 2014-04-02 Univ Wuhan Pflaster zur transdermalen absorption eines antivirus-wirkstoffs und verfahren zu seiner herstellung
KR101688061B1 (ko) 2014-10-06 2017-01-02 주식회사한국파마 필로카르핀 경피 흡수 제제
JP6526475B2 (ja) * 2015-04-30 2019-06-05 サンスター株式会社 経皮唾液腺投与用の唾液分泌促進剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
US4713244A (en) * 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US5273757A (en) * 1987-09-01 1993-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Apparatus for the delivery of substances, processes for the production thereof and use thereof
US5300291A (en) * 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5021053A (en) * 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
ATE167800T1 (de) * 1990-04-27 1998-07-15 Allergan Inc Polymeres arzneimittelabgabesystem

Also Published As

Publication number Publication date
CZ277995A3 (en) 1996-05-15
PL311281A1 (en) 1996-02-05
WO1994025025A2 (de) 1994-11-10
IL109340A0 (en) 1994-07-31
IL109340A (en) 1998-10-30
FI955161A0 (fi) 1995-10-27
KR960702308A (ko) 1996-04-27
AU694115B2 (en) 1998-07-16
DE4313928C2 (de) 1996-09-19
WO1994025025A3 (de) 1995-03-02
YU22894A (sh) 1997-08-22
DE4313928A1 (de) 1994-11-03
ZA942874B (en) 1995-07-06
HU9503087D0 (en) 1995-12-28
FI955161A (fi) 1995-11-24
NZ265950A (en) 1997-08-22
CA2161520A1 (en) 1994-11-10
NO954325D0 (no) 1995-10-27
HUT75029A (en) 1997-03-28
NO309174B1 (no) 2000-12-27
SK134395A3 (en) 1997-02-05
PL175077B1 (pl) 1998-10-30
EP0695182A1 (de) 1996-02-07
NO954325L (no) 1995-10-30
AU6648194A (en) 1994-11-21
US5869086A (en) 1999-02-09
HU220045B (hu) 2001-10-28
JPH08509716A (ja) 1996-10-15

Similar Documents

Publication Publication Date Title
EG20650A (en) Opioid formulations having extended controlled release
GR3036565T3 (en) Controlled release formulation
EP0720835A3 (de) Chirurgisches System
GB9314135D0 (en) Pretensioner for sealbelt system
ZA935569B (en) Controlled release implants
GB9305585D0 (en) Controlled release microcapsules
GB9425034D0 (en) Emergency response system
EG23934A (en) Poroxetine controlled release compositions
AU1247992A (en) Hydraulic release system
AU5895994A (en) Controlled release microspheres
EP0644756A4 (de) System zur kontrollierten freisetzung von antiarrhythmischen wirkstoffen.
GB2305263B (en) System for simplifying the implementation of specified functions
HRP940270A2 (en) Systems for controlled release of pilocarpine
HUP0002938A3 (en) Procedure and system for the setting up of calls
AU5702194A (en) Tablets for the controlled release of 4-asa
GB9213880D0 (en) Emergency release
AU4084997A (en) Method of inhibiting the release of bioactive il-1
GB2265995B (en) Hydraulic system
AU6997698A (en) System for controlled release of antiarrhythmic agents
AU3008192A (en) Release coat
GB9221242D0 (en) Emergency parchute stabilizator for helikopters
IL104282A0 (en) Sustained release system
CA73614S (en) Set of dinnerware
GB9222079D0 (en) C p system
AU2002300863A1 (en) Controlled Release Formulation

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected